RBC Capital analyst Frank Morgan maintained a Buy rating on Tenet Healthcare (THC) today and set a price target of $26.00. The company’s shares closed last Thursday at $19.87.
According to TipRanks.com, Morgan is a 5-star analyst with an average return of 9.1% and a 58.9% success rate. Morgan covers the Services sector, focusing on stocks such as Fresenius Medical Care, Genesis Healthcare, and Acadia Healthcare.
Tenet Healthcare has an analyst consensus of Moderate Buy, with a price target consensus of $29.57, representing a 40.8% upside. In a report issued on April 3, Credit Suisse also maintained a Buy rating on the stock with a $43.00 price target.
See today’s analyst top recommended stocks >>
Based on Tenet Healthcare’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $4.81 billion and net profit of $2 million. In comparison, last year the company earned revenue of $4.62 billion and had a GAAP net loss of $5 million.
Based on the recent corporate insider activity of 49 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of THC in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Tenet Healthcare Corp. engages in the provision of health care services. Through its subsidiaries and affiliates, it owns and facilitates acute care hospitals, ambulatory surgery centers, diagnostic imaging centers, and related health care facilities. It operates through the following business segments: Hospital Operations and Other, Ambulatory Care, and Conifer. The Hospital Operations and Other segment comprises of acute care hospitals, ancillary outpatient facilities, urgent care centers, microhospitals and physician practices. The Ambulatory Care segment includes operations of USPI joint venture and the company’s nine Aspen facilities in the United Kingdom. The Conifer segment offers healthcare business process services in the areas of hospital and physician revenue cycle management and value-based care solutions to healthcare systems, as well as individual hospitals, physician practices, self-insured organizations, health plans, and other entities. The company was founded in 1975 and is headquartered in Dallas, TX.
